Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.
Saved in:
| Title: | Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer. |
|---|---|
| Authors: | Ruiz-Torres DA; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Merkin RD; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA., Bryan ME; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mendel J; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA., Efthymiou V; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA., Roberts T; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA., Patel MJ; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA., Park JC; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA., Chevalier A; NeoGenomics, Inc., Fort Meyers, FL, USA., Murray C; NeoGenomics, Inc., Fort Meyers, FL, USA., Gates L; NeoGenomics, Inc., Fort Meyers, FL, USA., Pipinikas C; NeoGenomics, Inc., Fort Meyers, FL, USA., Stott SL; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Engineering in Medicine & Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Fisch AS; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Wirth LJ; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA., Faden DL; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA. dfaden@mgb.org.; Department of Medicine, Harvard Medical School, Boston, MA, USA. dfaden@mgb.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. dfaden@mgb.org.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA. dfaden@mgb.org. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2025 Aug 22; Vol. 9 (1), pp. 298. Date of Electronic Publication: 2025 Aug 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40846896 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ruiz-Torres+DA%22">Ruiz-Torres DA</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Merkin+RD%22">Merkin RD</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bryan+ME%22">Bryan ME</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mendel+J%22">Mendel J</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Efthymiou+V%22">Efthymiou V</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Roberts+T%22">Roberts T</searchLink>; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Patel+MJ%22">Patel MJ</searchLink>; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Park+JC%22">Park JC</searchLink>; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chevalier+A%22">Chevalier A</searchLink>; NeoGenomics, Inc., Fort Meyers, FL, USA.<br /><searchLink fieldCode="AU" term="%22Murray+C%22">Murray C</searchLink>; NeoGenomics, Inc., Fort Meyers, FL, USA.<br /><searchLink fieldCode="AU" term="%22Gates+L%22">Gates L</searchLink>; NeoGenomics, Inc., Fort Meyers, FL, USA.<br /><searchLink fieldCode="AU" term="%22Pipinikas+C%22">Pipinikas C</searchLink>; NeoGenomics, Inc., Fort Meyers, FL, USA.<br /><searchLink fieldCode="AU" term="%22Stott+SL%22">Stott SL</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Engineering in Medicine & Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fisch+AS%22">Fisch AS</searchLink>; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wirth+LJ%22">Wirth LJ</searchLink>; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Faden+DL%22">Faden DL</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, USA. dfaden@mgb.org.; Department of Medicine, Harvard Medical School, Boston, MA, USA. dfaden@mgb.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. dfaden@mgb.org.; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA. dfaden@mgb.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2025 Aug 22; Vol. 9 (1), pp. 298. <i>Date of Electronic Publication: </i>2025 Aug 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40846896 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41698-025-01084-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 298 Titles: – TitleFull: Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ruiz-Torres DA – PersonEntity: Name: NameFull: Merkin RD – PersonEntity: Name: NameFull: Bryan ME – PersonEntity: Name: NameFull: Mendel J – PersonEntity: Name: NameFull: Efthymiou V – PersonEntity: Name: NameFull: Roberts T – PersonEntity: Name: NameFull: Patel MJ – PersonEntity: Name: NameFull: Park JC – PersonEntity: Name: NameFull: Chevalier A – PersonEntity: Name: NameFull: Murray C – PersonEntity: Name: NameFull: Gates L – PersonEntity: Name: NameFull: Pipinikas C – PersonEntity: Name: NameFull: Stott SL – PersonEntity: Name: NameFull: Fisch AS – PersonEntity: Name: NameFull: Wirth LJ – PersonEntity: Name: NameFull: Faden DL IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 08 Text: 2025 Aug 22 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2397-768X Numbering: – Type: volume Value: 9 – Type: issue Value: 1 Titles: – TitleFull: NPJ precision oncology Type: main |
| ResultId | 1 |